webinar register page

Webinar banner
Update from Avadel on investigational clinical treatment
Avadel explains the recent FDA tentative approval of LUMRYZ™ (sodium oxybate) extended-release oral suspension, an investigational narcolepsy clinical treatment (formerly known as FT218), and addresses questions from the community.

Aug 10, 2022 08:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Narcolepsy Network.